Am J Transplant, Volume 22, Suppl 3 Archives - Page 100 of 190 - ATC Abstracts

2022 American Transplant Congress
Impact of a Pharmacist on Transitions and Ambulatory Outcomes in Lung Transplant Recipients
A. Yang, R. McKnight, A. Prom, M. Byrne, R. Evans, C. Doligalski
UNC Health, Chapel Hill, NC
*Purpose: Minimal data exists describing the impact of a pharmacist in transitions of care (TOC) and ambulatory medication management in lung transplant recipients (LTRs). Following…
2022 American Transplant Congress
Achievement of Persistent Mixed Chimerism in Recipients of Matched and Mismatched Living Donor Kidney Transplants in a Tolerance Induction Protocol
J. D. Scandling, S. Busque, R. Lowsky, T. Pham, R. Hoppe, K. Jensen, A. Shori, H. Wu, R. Pawar, E. Engleman, E. Meyer, S. Strober
Stanford University School of Medicine, Stanford, CA
*Purpose: The induction of tolerance to kidney transplants after development of specific unresponsiveness of recipient immune cells to donor alloantigens allows elimination of maintenance immunosuppressive…
2022 American Transplant Congress
Electrospun Poly-ε-Caprolactone Scaffolds Incorporating Decellularized Extracellular Matrix for Suturable Tissue Engineered Small Vascular Graft
A. Han¹, S. Min¹, E. Cho¹, H. Woo¹, A. Cho¹, J. Ha¹, Y. Ju², S. Min¹
¹Department of Surgery, Seoul National University College of Medicine, Seoul, Korea, Republic of, ²Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC
*Purpose: While small-sized grafts (1-5mm in diameter) are essential vascular conduits needed to replace diseased end arteries supplying vital organs or tissues, the use of…
2022 American Transplant Congress
Achieving Balanced Altruism for Compatible Pairs (CP) Participating in KPD Program: A Single Centre Experience
K. Almeshari¹, D. Broering², I. Alahmadi³, T. Ali¹, F. Alzayer⁴, M. Mankowski⁵, A. Algharabli¹
¹Kidney & Pancreas Health Centre, OTCoE, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia, ²Organ Transplant Centre of Excellence, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia, ³Kidney & Pancreas Transplant Surgery, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia, ⁴King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia, ⁵King Abdullah University for Science & Technology, Riyadh, Saudi Arabia
*Purpose: To avoid the potential for unbalanced altruism for the participation of CP in KPD programs, we sought to define clear criteria for their inclusion…
2022 American Transplant Congress
A Single-Center’s Outcomes of Combined Heart-Liver Transplantation
R. W. Lincoln¹, K. Kalvakuri², A. Guha², A. Bhimaraj², E. E. Suarez², A. Saharia³, C. M. Mobley³, F. Amirkhosravi³, J. Krisl¹
¹Pharmacy, Houston Methodist Hospital, Houston, TX, ²DeBakey Heart and Vascular Associates, Houston Methodist Hospital, Houston, TX, ³Surgery, Houston Methodist Hospital, Houston, TX
*Purpose: The purpose of this study was to evaluate rejection outcomes in our combined heart-liver transplant (CHLT) recipients at 6 months.*Methods: This is a retrospective,…
2022 American Transplant Congress
Impact of Low Dose Donor-Specific HLA Antibodies in Living and Deceased Donor Kidney Transplantation
H. Lee¹, I. Sun², C. Yang¹, B. Chung¹
¹Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's hospital, Seoul, Korea, Republic of, ²Division of Nephrology, Department of Internal Medicine., Presbyterian Medical Center, Jeonju, Korea, Republic of
*Purpose: The prognostic value of low level preformed donor-specific antibodies (DSA) remains controversial for kidney transplantation. The aim of the present study was to investigate…
2022 American Transplant Congress
Impaired Humoral Response to Second Dose of BNT162b2 Messenger RNA COVID-19 Vaccine in Kidney Transplant Recipients in Japan: Prospective Observational Study
H. Sasaki¹, K. Hasegawa¹, M. Miura², H. Harada¹, D. Takamoto¹, Y. Takada¹, S. Harada¹, H. Tanaka¹
¹Sapporo City General Hospital, Sapporo, Japan, ²Sapporo Hokuyu Hospital, Sapporo, Japan
*Purpose: The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has a major impact on solid organ transplant (SOT) recipients, with mortality rate up to 22%. The…
2022 American Transplant Congress
Bcl6b is a Putative Regulator of Endothelial Identity and Endmt
N. M. Valenzuela
Pathology and Laboratory Medicine, UCLA, Los Angeles, CA
*Purpose: Loss of endothelial cell (EC) identity is central to endothelial to mesenchymal transition (EndMT) implicated in neointimal hyperplasia in transplant vasculopathy. However, the molecular…
2022 American Transplant Congress
Differences in Post-Liver Transplant Hospitalizations by Patient Race
K. Ross-Driscoll¹, R. Lynch¹, J. Wedd², R. Patzer¹
¹Emory University, Atlanta, GA, ²Virginia Commonwealth University, Richmond, VA
*Purpose: Hospital admissions after liver transplant are common, costly, and associated with poor outcomes. While survival disparities are well-documented for Black liver recipients, little is…
2022 American Transplant Congress
An Updated Estimate of Post-Transplant Survival After Implementation of the New Donor Heart Allocation Policy
K. A. Lazenby¹, N. Narang², K. M. Pelzer³, G. Ran¹, W. F. Parker³
¹Pritzker School of Medicine, University of Chicago, Chicago, IL, ²Advocate Heart Institute, Advocate Christ Medical Center, Chicago, IL, ³Department of Medicine, University of Chicago, Chicago, IL
*Purpose: Published estimates showing lower post-transplant survival after implementation of the new heart allocation policy may be biased downward due to incomplete follow-up on surviving…